- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05325086
Effect on Quality of Life of Adapted Information in Pulmonary Rehabilitation in Chronic Respiratory Disease Patients
Effect on Quality of Life of Information Aimed at Reducing the Impact of a Personality Trait (Openness to Experiences) Identified as a Risk of Non-response to Pulmonary Rehabilitation in Patients With Chronic Respiratory Diseases
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
According to the Five Factor Model, personality is made of five dimensions present in varying degrees in individuals and influencing their behavior and life experiences. Several studies showed that some personality traits, according to their level, may positively or negatively influence the quality of life. They can also have an impact on the benefits obtained at the end of one treatment. In the particular context of pulmonary rehabilitation (PR) which is one of the most efficient treatment in respiratory diseases, it has been showed that with a classical support, higher scores for openness to experiences represent a risk factor for non-response in PR on quality of life (i.e. no improvement). Several authors showed that adapted interventions (ex: simple information booklets), based on personality traits, can enhance the effectiveness of the intervention.
Considering that in chronic respiratory diseases, openness to experiences when it is more marked represents a risk of not improving the quality of life following a PR program, the idea of offering information in line with the characteristics of these people (i.e., search for novelties, autonomy, broad and varied interests, etc.) seems relevant and feasible.
The investigators hypothesize that the patients receiving an adapted information aimed at reducing the impact of a personality trait (openness to experiences) will better improve their quality of life in comparison with the patients receiving a neutra information.
The main objective is to assess the impact of life of an adapted information during pulmonary rehabilitation on quality in patients with chronic respiratory diseases.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Hauteville-Lompnes, France, 01110
- Clinique du Souffle le Pontet
-
Riom-ès-Montagnes, France
- Clinique du Souffle Les Clarines
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
Admitted for a 4-week inpatient pulmonary rehabilitation program Chronic respiratory disease diagnosis 18 and 80 years old Reading and writing skills Oral consent
Exclusion Criteria:
Inability to participate to exercise training Inability to answer a questionnaire Severe or unstable heart disease, orthopedic, neurologic or psychiatric comorbidities Recent exacerbation (<4 weeks) Pregnant and breastfeeding women Protected adults, pregnant women Participation in another study, with the exception of observational studies
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Adapted information arm
In parallel with an inpatient PR program, 4 visits will be carried out: V0 : Inclusion / V1 : Randomization / V2 : Follow-up / V3: End-stay. At V1:
At V2: *Semi-structured individual interviews will be performed. Questions will relate to the information distributed during V1 (adapted information), allowing to assess the understanding and the appropriation of it. At V3:
|
A adapted booklet will be delivered to patients at the start of the stay.
This booklet contains adapted information about the pulmonary rehabilitation targetting the characteristics of the openness to experiences personality traits
|
|
Sham Comparator: Neutral information arm
In parallel with an inpatient PR program, 4 visits will be carried out: V0 : Inclusion / V1 : Randomization / V2 : Follow-up / V3: End-stay. At V1:
At V2: *Semi-structured individual interviews will be performed. Questions will relate to the information distributed during V1 (neutral information), allowing to assess the understanding and the appropriation of it. At V3:
|
A neutral booklet will be delivered to patients at the start of the stay.
This booklet contains neutral information about the pulmonary rehabilitation
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Differential of health-related quality of life from baseline to PR end-stay
Time Frame: Changes from baseline (T0) to at the end of the 4-weeks PR (T1)
|
Assessing differential of health-related quality of life score on St. George's Respiratory Questionnaire (SGRQ) (Jones et al., 1991) from baseline to PR end-stay within and between groups The SGRQ contains 50 questions and evaluates 3 dimensions : symptoms component, activities that cause or are limited by breathlessness and impact component |
Changes from baseline (T0) to at the end of the 4-weeks PR (T1)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Differential of dyspnea from from baseline to PR end-stay
Time Frame: Changes from baseline (T0) to at the end of the 4-weeks PR (T1)
|
Assessing differential of dyspnea score on DYSPNEA-12 questionnaire (Yorke et al 2010) within and between groups. The Dyspnea-12 contains 12items and evaluate the physical and affective dimensions of dyspnea. |
Changes from baseline (T0) to at the end of the 4-weeks PR (T1)
|
|
Differential of exercise tolerance from from baseline to PR end-stay
Time Frame: Changes from baseline (T0) to at the end of the 4-weeks PR (T1)
|
Assessing differential of exercise tolerance on the 6-minute walking test within and between groups.
|
Changes from baseline (T0) to at the end of the 4-weeks PR (T1)
|
|
Differential of self-efficacy from from baseline to PR end-stay
Time Frame: Changes from baseline (T0) to at the end of the 4-weeks PR (T1)
|
Assessing differential of self-efficacy score on Self-efficacy for managing chronic disease SEMCD-6 questionnaire (Ritter & Lorig, 2014) within and between groups.
This questionnaire contains 6 items.
|
Changes from baseline (T0) to at the end of the 4-weeks PR (T1)
|
|
Differential of disease-related thinking from from baseline to PR end-stay
Time Frame: Changes from baseline (T0) to at the end of the 4-weeks PR (T1)
|
Assessing differential of disease-related thinking score on Brief Illness Perception Questionnaire B-IPQ (Broadbent et al., 2006) within and between groups. This questionnaire contains 8 items. |
Changes from baseline (T0) to at the end of the 4-weeks PR (T1)
|
|
Differential of disease-related fears from from baseline to PR end-stay
Time Frame: Changes from baseline (T0) to at the end of the 4-weeks PR (T1)
|
Assessing differential of disease-related fears score on COPD Anxiety Questionnaire Revised CAF-R (Keil et al., 2014) within and between groups. This questionnaire contains 20 items. |
Changes from baseline (T0) to at the end of the 4-weeks PR (T1)
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Benjamin EICHENAUER, Korian
- Study Director: Nelly HERAUD, Korian
- Study Director: Brice CANADA, Université de Lyon
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- MONTREHAL-1
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Chronic Respiratory Disease
-
Skane University HospitalLund University; The Swedish Research Council; ResMed; Vastra Gotaland Region; Region... and other collaboratorsRecruitingInterstitial Lung Disease | Chronic Respiratory Failure With Hypoxia | Chronic Obstructive Pulmonary Disease SevereSweden
-
Aveiro UniversityPrograma Operacional Inclusão Social e Emprego (POISE); Programa Operacional... and other collaboratorsCompletedLung Diseases | Chronic Obstructive Pulmonary Disease | Pulmonary Disease | Interstitial Lung Disease | Chronic Respiratory DiseasePortugal
-
Innowage LimitedGyansanjeevani India; Mettle NetworksCompletedRespiration Disorders | Respiratory Tract Disorders | Chronic Disease Management | Pulmonary Diseases or Conditions | Chronic Respiratory ConditionsIndia
-
Aveiro UniversityFundação para a Ciência e a TecnologiaRecruitingChronic Respiratory DiseasePortugal
-
University Hospital, BrestRecruiting
-
University Hospital, Gentofte, CopenhagenPhilips RespironicsUnknownChronic Obstructive Pulmonary Disease | Chronic Hypercapnic Respiratory Failure | Acute Exacerbation of Chronic Obstructive Airways DiseaseDenmark
-
AstraZenecaCompletedChronic Obstructive Pulmonary Disease (COPD) | Chronic BronchitisUnited States, Canada, Denmark, Spain, United Kingdom, Taiwan, New Zealand, Australia, Germany, Israel, South Africa, Czechia, Hungary, Poland, Netherlands
-
IRCCS Azienda Ospedaliero-Universitaria di BolognaUnknownChronic Respiratory Failure | Chronic Obstructive Pulmonary Disease PatientsItaly
-
University of Alabama at BirminghamNational Heart, Lung, and Blood Institute (NHLBI); Vertex Pharmaceuticals IncorporatedCompletedChronic Obstructive Pulmonary Disease | Chronic BronchitisUnited States
-
Al-Azhar UniversityCompletedChronic Obstructive Pulmonary Disease | Respiratory FailureEgypt
Clinical Trials on Adapted information arm
-
University of MinnesotaNational Institute on Deafness and Other Communication Disorders (NIDCD)CompletedDysphonia | Voice Disorders | Functional DysphoniaUnited States
-
Northwestern UniversityNational Institute of Mental Health (NIMH); National Institutes of Health (NIH)Recruiting
-
University Hospital, Clermont-FerrandRecruitingSleep | Child, Only | Blood Cancer | Adapted Physical ActivityFrance
-
Barbara Ann Karmanos Cancer InstituteNational Cancer Institute (NCI)RecruitingCulturally Adapting an Intervention to Increase Genetic Testing in African American Cancer SurvivorsProstate Cancer | Colorectal Carcinoma | Female Breast CancerUnited States
-
Massachusetts General HospitalNational Institute on Aging (NIA); University of California, DavisActive, not recruitingEmergenciesUnited States
-
San Francisco Department of Public HealthCenters for Disease Control and PreventionCompletedHIV Infections | Episodic Substance UseUnited States
-
University of SfaxCompleted
-
Hospices Civils de LyonCompleted
-
Amsterdam UMC, location VUmcCompletedPhysical ActivityNetherlands